Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA To Release Three DTC Draft Guidances: Disease Awareness Is One Focus

Executive Summary

FDA's upcoming draft guidances on direct-to-consumer advertising will encourage more use of disease awareness ads, Associate Commissioner for External Relations Peter Pitts said in a Jan. 23 speech to the advocacy group Families USA in Washington, D.C

You may also be interested in...



FDA External Relations Head Pitts Will Leave Agency For New York PR Firm

FDA Associate Commissioner for External Relations Peter Pitts is leaving after 14 months at the agency to join the public relations firm Manning, Selvage & Lee

FDA External Relations Head Pitts Will Leave Agency For New York PR Firm

FDA Associate Commissioner for External Relations Peter Pitts is leaving after 14 months at the agency to join the public relations firm Manning, Selvage & Lee

Disease Awareness Ad Guidance Stresses Need For “Distinct” Messages

The impact of FDA's draft guidance on disease awareness ads will depend upon how willing manufacturers are to allot portions of their advertising budgets to non-branded ads

Related Content

Latest News
See All
UsernamePublicRestriction

Register

PS043208

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel